A bipartisan group of senators is nearing a deal to rein in prescription drug prices (via axios)
This story requires our BI Prime membership. To read the full article,A group of senators is considering a plan to limit how much drug companies can raise their prices in Medicare's prescription drug benefit, among other changes.
While some parts of the package have been met with general agreement — such as capping out-of-pocket costs for seniors — others are more controversial. A group of senators is considering a plan to limit how much drug companies can raise their prices in Medicare's prescription drug benefit, among other changes.Some of the proposals would majorly restructure the way Medicare pays for drugs and are sure to draw massive industry pushback — if lawmakers can even agree to them.Senate Finance Committee Chairman Chuck Grassley and the committee's top Democrat, Ron Wyden, have been negotiating a drug price package.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Trump Rule Requiring Drug Prices in TV Ads BlockedA federal judge sides with manufacturers, saying the regulation would violate free speech. It was a key part of the president’s push to lower the cost of prescription medication.
Leer más »
Judge blocks Trump administration bid to require drug prices in TV ads
Leer más »
Judge rules Trump administration can't require drug prices in TV adsA federal judge in Washington struck down a Trump administration plan that would have required drugmakers to include pricing information in ads seen on TV.
Leer más »
Judge blocks Trump rule requiring drug ads to reveal pricesA federal judge has blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads.
Leer más »
Frank Pallone and Nancy Pelosi rein in the leftRep. Frank Pallone has become one of Speaker Nancy Pelosi's key allies to contain the Democratic Party's aggressive liberal surge
Leer más »